Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Convergence Insufficiency Treatment Trial - Attention and Reading Trial (CITT-ART)

NCT02207517 is registered in ClinicalTrials.gov with Salus University as lead sponsor.

NCT NCT02207517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02207517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Convergence Insufficiency Treatment Trial - Attention and Reading Trial (CITT-ART)
Lead sponsor
Salus University
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2014
Completion date
November 30, 2020
Enrollment
311 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

convergence insufficiency